AU2001266189A1 - Materials and methods relating to gene delivery - Google Patents
Materials and methods relating to gene deliveryInfo
- Publication number
- AU2001266189A1 AU2001266189A1 AU2001266189A AU6618901A AU2001266189A1 AU 2001266189 A1 AU2001266189 A1 AU 2001266189A1 AU 2001266189 A AU2001266189 A AU 2001266189A AU 6618901 A AU6618901 A AU 6618901A AU 2001266189 A1 AU2001266189 A1 AU 2001266189A1
- Authority
- AU
- Australia
- Prior art keywords
- materials
- gene delivery
- methods relating
- relating
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000001476 gene delivery Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/554—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Botany (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0015624.0A GB0015624D0 (en) | 2000-06-26 | 2000-06-26 | Materials and methods relating to improved gene delivery |
GB0015624 | 2000-06-26 | ||
PCT/GB2001/002859 WO2002000680A2 (fr) | 2000-06-26 | 2001-06-26 | Materiaux et procedes relatifs a l'administration de genes |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001266189A1 true AU2001266189A1 (en) | 2002-01-08 |
Family
ID=9894419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001266189A Abandoned AU2001266189A1 (en) | 2000-06-26 | 2001-06-26 | Materials and methods relating to gene delivery |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001266189A1 (fr) |
GB (1) | GB0015624D0 (fr) |
WO (1) | WO2002000680A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10109898A1 (de) * | 2001-02-21 | 2002-09-05 | Novosom Gmbh | Lipide mit veränderlicher Ladung |
CN115487168A (zh) * | 2022-09-27 | 2022-12-20 | 浙江大学 | 一种基于含氮杂环胆固醇衍生物的脂质纳米颗粒及其应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6071890A (en) * | 1994-12-09 | 2000-06-06 | Genzyme Corporation | Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy |
AU701106B2 (en) * | 1995-06-07 | 1999-01-21 | Promega Biosciences, Inc. | Novel carbamate-based cationic lipids |
WO1997004748A2 (fr) * | 1995-08-01 | 1997-02-13 | Advanced Therapies, Inc. | Enveloppes virales artificielles renforcees pour l'apport de substances therapeutiques dans les cellules |
WO1997039019A1 (fr) * | 1996-04-12 | 1997-10-23 | University Of Pittsburgh | Nouveaux derives de cholesteryle cationiques contenant des groupes polaires cycliques |
US5912239A (en) * | 1997-04-04 | 1999-06-15 | Genzyme Corporation | Imidazole-containing cationic amphiphiles for intracellular delivery of therapeutic molecules |
-
2000
- 2000-06-26 GB GBGB0015624.0A patent/GB0015624D0/en not_active Ceased
-
2001
- 2001-06-26 AU AU2001266189A patent/AU2001266189A1/en not_active Abandoned
- 2001-06-26 WO PCT/GB2001/002859 patent/WO2002000680A2/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
GB0015624D0 (en) | 2000-08-16 |
WO2002000680A3 (fr) | 2002-05-16 |
WO2002000680A2 (fr) | 2002-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001232049A1 (en) | Improvements in and relating to controlling drug delivery apparatus | |
AU2002364148A1 (en) | Delivering content and advertisement | |
AU2002235128A1 (en) | Expression miniarrays and uses thereof | |
AU2002225681A1 (en) | Yeast-dentritic cell vaccines and uses thereof | |
AU2001280767A1 (en) | Peptide-mediated delivery of molecules into cells | |
AU6768301A (en) | Materials and methods relating to the increase in protein activity | |
AU6887401A (en) | Delivery of remotely-ordered products | |
AU2002365188A1 (en) | Nucleic acid delivery and expression | |
AU2001288061A1 (en) | Drug resistance-associated gene and use thereof | |
AU2001227900A1 (en) | Drug metabolizing enzymes | |
AU2001238485A1 (en) | Methods and compositions for gene delivery | |
AUPQ659800A0 (en) | Genetic sequences and uses therefor | |
AU2001274981A1 (en) | Drug metabolizing enzymes | |
AUPR311601A0 (en) | Matrix gene expression in chondrogenesis | |
AU2001270303A1 (en) | Drug metabolizing enzymes | |
AU2001297738A1 (en) | Gene delivery device and gene delivery method | |
AU2001270478A1 (en) | Gene expression in biological conditions | |
AU6094200A (en) | Nor gene compositions and methods for use thereof | |
AU2001274566A1 (en) | Novel protein and dna thereof | |
AU2001255324A1 (en) | Drug metabolizing enzymes | |
AU2001235000A1 (en) | Drug metabolizing enzymes | |
AU2153401A (en) | Gene expression in biological conditions | |
AU2001266189A1 (en) | Materials and methods relating to gene delivery | |
AU1894601A (en) | Novel gene and use thereof | |
AU2001268053A1 (en) | Human sparc-homologous (hsparc-h1) gene and methods and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase | ||
TH | Corrigenda |
Free format text: IN VOL 16, NO 12, PAGE(S) 2688-2711 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 50578/00, 50580/00, 55758/00, 57119/00, 58642/00, 70409/00, 11771/01, 19844/01, 22347/01, 24081/01, 56837/01, 58896/01, 58898/01, 61914/01, 62021/01, 62771/01, 62783/01, 62803/01, 62804/01, 64355/01, 64359/01, 64360/01, 64361/01, 64364/01, 64366/01, 64369/01, 65685/01, 66189/01, 66319/01, 69200/01, 70677/01, 72586/01, 74264/01, 74277/01, 74317/01, 74344/01, 74400/01, 74649/01, 84539/01, 85731/01, 13599/02 |